InVivo Therapeutics Holdings Corp. Appoints Richard Toselli as Chief Medical Officer
July 10, 2017 at 08:00 am
InVivo Therapeutics Holdings Corp. announced the appointment of Richard Toselli, M.D., as Chief Medical Officer, effective July 5, 2017. Dr. Toselli, a fellowship-trained spinal neurosurgeon, will assume all responsibilities related to the company’s clinical and regulatory strategy. Prior to joining InVivo, Dr. Toselli served as Chief Medical Officer for Cochlear Limited. In that role, he was responsible for global clinical, regulatory, and medical affairs teams reporting to the CEO.